Ingen Technologies, Inc.
IGNT - Insider Information
Get informed when a big investor buys or sells
+ FollowMarket Cap$896
Close$
Insider Trades
Loading insider trades…
Congress Trades
Loading congress trades…
Share Statistics
| Market cap | $896.00 |
|---|---|
| Enterprise Value | $3.26 Million |
| Earnings per Share | $0 |
| Beta | -9.07 |
| Outstanding Shares | 9 |
Return
| Return on Equity | 27.29% |
|---|---|
| Return on Assets | -637.91% |
| Return on Invested Capital | 50.64% |
Valuation & Multiples
| P/E Ratio | -0.03 |
|---|---|
| PEG | 0 |
| Price to Sales | 0.0 |
| Price to Book Ratio | -0.0 |
| Enterprise Value to Revenue | 12.66 |
| Enterprise Value to EBIT | -1.72 |
| Enterprise Value to Net Income | -2 |
| Total Debt to Enterprise | 1 |
| Debt to Equity | -0.3 |
Revenue Sources
No data
Institutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
About Ingen Technologies, Inc.
155 employees
CEO: Dave Hanson
Ingen Technologies, Inc. engages in the manufacture of respiratory medical devices. Its products include oxygen flow meters and nasal cannulas that trade under the trademark name of Oxyview and Smart Nasal Cannula. The company was founded in 1999 and is headquartered in Riverside, CA.